HMGA2 and breast cancer: Although WP’s involvement in the subtype specific BC has been reported recently, in the context of HMGA2 induction and proliferation in metastatic triple-negative breast cancer [21], its role in the context of BC heterogeneity, subtype specific genomic events, and outcome remains undecided.